Stockscreener 앱 받기
0.58
4.13%
-0.025
시간 외 거래:
.60
0.02
+3.45%
전일 마감가:
$0.605
열려 있는:
$0.592
하루 거래량:
75,012
Relative Volume:
0.22
시가총액:
$5.13M
수익:
$11.42M
순이익/손실:
$-2.89M
주가수익비율:
-1.5223
EPS:
-0.381
순현금흐름:
$-1.38M
1주 성능:
-1.79%
1개월 성능:
+1.38%
6개월 성능:
-71.29%
1년 성능:
-78.68%
1일 변동 폭
$0.5712
$0.6036
1주일 범위
$0.5712
$0.63
52주 변동 폭
$0.56
$2.8899
Nexgel Inc Stock (NXGL) Company Profile
명칭
Nexgel Inc
전화
215 702-8550
주소
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NXGL
Nexgel Inc
|
0.58 | 5.35M | 11.42M | -2.89M | -1.38M | -0.381 |
ISRG
Intuitive Surgical Inc
|
431.87 | 148.77B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.51 | 39.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.55 | 33.19B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.78 | 30.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.79 | 28.83B | 5.54B | 1.52B | 1.74B | 10.37 |
Nexgel Inc 주식(NXGL)의 최신 뉴스
NEXGEL Strengthens Board with Sequence LifeScience Leaders - TipRanks
[8-K] NEXGEL, INC. Reports Material Event - Stock Titan
Earnings Preview: NexGel to Report Financial Results Pre-market on May 15 - 富途牛牛
NEXGEL, Inc. to Announce First Quarter 2026 Financial Results on May 15, 2026, with Conference Call Scheduled for 12:00 P.M. ET - Quiver Quantitative
NEXGEL To Report First Quarter 2026 Financial Results on May 15th - GlobeNewswire
TradingKey - TradingKey
NexGel (NXGL) Eps Diluted (TTM) - Zacks Investment Research
Nexgel Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
NXGLW NexGel Inc warrant holders await quarterly earnings details as report data remains unavailable, stock movement muted today.Merger - newser.com
NEXGEL (NXGL) CFO details warrants, convertible note and 160,000-share option - Stock Titan
Sequence LifeScience, Inc. announced that it has received $5.5 million in funding from NEXGEL, Inc. - marketscreener.com
After $5.5M deal backing, Sequence executives take 2 NEXGEL board seats - Stock Titan
NEXGEL Appoints Ian Blackman CFO Amid Celularity Deal - MyChesCo
NexGel Inc Warrant (NXGLW) - Minichart
NexGel, Inc. 2025 SEC Filing – Executive Compensation, Corporate Governance, Ownership & Audit Disclosure - Minichart
NexGel Appoints Ian Blackman as New Chief Financial Officer - The Globe and Mail
Maxim Group Maintains NexGel(NXGL.US) With Buy Rating, Maintains Target Price $2 - Moomoo
Board pay, ownership and new CFO terms at NexGel (NASDAQ: NXGL) - Stock Titan
Ian Blackman named CFO of Nex; Adam E. Drapczuk III resigns as Interim CFO - TradingView
NEXGEL (NASDAQ: NXGL) hires new CFO to support Celularity deal - Stock Titan
NEXGEL Closes Celularity Asset Deal, Launches BioNX Surgical - MyChesCo
Asymmetry Point LP (NXGL) files Schedule 13G/A showing 8.8% ownership - Stock Titan
NEXGEL expects pro forma annual revenue of roughly $35M following Celularity wound segment acquisition - MSN
Langhorne’s Nexgel Transforms Near Disaster into ‘Three-Team Trade’ Acquisition - BUCKSCO.Today
NEXGEL Appoints Ian Blackman as Chief Financial Officer - Investing News Network
Nexgel, Inc. Appoints Ian Blackman as Chief Financial Officer - marketscreener.com
Inside the deal: After investor bails, Nexgel scrambles to save acquisition that will triple revenue - The Business Journals
NexGel Receives Nasdaq Deficiency Notice Over Bid Price - The Globe and Mail
NexGel receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com India
NXGL SEC FilingsNexgel Inc 10-K, 10-Q, 8-K Forms - Stock Titan
NEXGEL, INC. Receives Nasdaq Delisting Notice for Failure to Meet Minimum Bid Price Requirement - Minichart
NexGel receives Nasdaq notice for minimum bid price deficiency - Investing.com
NexGel Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
NexGel (NASDAQ: NXGL) warned by Nasdaq over sub-$1 share price and delisting risk - Stock Titan
NXGL (NexGel Inc) shares fall over 15 percent after Q4 2025 EPS loss lands far below analyst consensus estimates.Fast Rising Picks - Xã Thanh Hà
NXGLW NexGel Inc prioritizes expansion of its over-the-counter medical product lines to fuel future revenue growth.Best Pick - newser.com
NexGel Bets Big With Transformational Acquisition And Financing - TipRanks
NEXGEL Reschedules Shareholder Call, Revises Celularity Financing - MyChesCo
Latest NXGL NewsNEXGEL to Present at H.C. Wainwright's Bioc... - Stock Titan
NEXGEL closes Celularity biomaterials deal, raises $5.5 million By Investing.com - Investing.com India
Celularity Closes $13.3 Million Asset Sale to NexGel, Strengthening Focus on Longevity Therapeutics and Balance Sheet 1 - Minichart
Celularity Announces Closing of Transaction with NexGel - Investing News Network
NXGL: Acquisition triples revenue and accelerates profitability, transforming the business platform - TradingView
Nexgel Inc co and Celularity enter amendment no. 1 to license agreement on April 17, 2026 - marketscreener.com
Nexgel IncCo to Pay Celularity $13.3 Mln I - Moomoo
NEXGEL Secures Strategic Financing and Regenerative Portfolio License - TipRanks
NexGel Closes Celularity Biomaterials License Terms and Secures $6.9M Convertible Note Financing - TradingView
NEXGEL (NASDAQ: NXGL) triples revenue outlook with Celularity deal, $6.9M notes - Stock Titan
Celularity Inc. announced that it has received $13.3 million in funding from NEXGEL, Inc. - marketscreener.com
NexGel closes acquisition of products from Celularity - TipRanks
NEXGEL New Strategic Partner, Sequence LifeScience, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment - Investing News Network
Nexgel Inc (NXGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.05%
3.17%
자본화:
|
볼륨(24시간):